Circulating matrix metalloproteinases and their inhibitors in inguinal hernia and abdominal aortic aneurysm

International Angiology

Volumn 30, Issue 2, 2011, Pages 123-129

  Antoniou, G A ^a,b   Tentes, I K ^a   Antoniou, S A ^a   Georgiadis, G S ^a   Giannoukas, A D ^b   Simopoulos, C ^a   Lazarides, M K ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Aortic aneurysm; Biomarkers; Hernia; Matrix metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ANALYSIS; HUMAN; INGUINAL HERNIA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GREECE; HERNIA, INGUINAL; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 79955755685     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wassef M, Baxter BT, Chisholm RL, Dalman RL, Fill inger MF, Heinecke J et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Insti tute. J Vasc Surg 2001;34:730-8. (Pubitemid 33664926)
2. Pearce WH, Shively VP. Abdominal aortic aneurysm as a complex multifactorial disease: interactions of poly morphisms of inflammatory genes, features of autoim munity, and current status of MMPs. Ann N Y Acad Sci 2006;1085:117-32. (Pubitemid 47091997)
3. Klinge U, Zheng H, Si ZY, Schumpelick V, Bhardwaj R, Klosterhalfen B. Synthesis of type I and III collagen, expression of fibronectin and matrix metalloproteinases-1 and -13 in hernial sac of patients with inguinal hernia. Int J Surg Investig 1999;1:219-27.
4. Bellón JM, Buján J, Honduvilla NG, Jurado F, Gimeno MJ, Turnay J et al. Study of biochemical substrate and role of metalloproteinases in fascia transversalis from hernial processes. Eur J Clin Invest 1997;27:510-6. (Pubitemid 27288362)
5. Abci I, Bilgi S, Altan A. Role of TIMP-2 in fascia transver salis on development of inguinal hernias. J Invest Surg 2005;18:123-8. (Pubitemid 41052005)
6. Salameh JR, Talbott LM, May W, Gosheh B, Vig PJ, McDaniel DO. Role of biomarkers in incisional hernias. Am Surg 2007;73:561-7. (Pubitemid 351396646)
7. Zheng H, Si Z, Kasperk R, Bhardwaj RS, Schumpelick V, Klinge U et al. Recurrent inguinal hernia: disease of the collagen matrix? World J Surg 2002;26:401-8.
8. Bellon JM, Bajo A, Ga-Honduvilla N, Gimeno MJ, Pascual G, Guerrero A et al. Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression. Ann Surg 2001;233:287-91.
9. Klinge U, Zheng H, Si Z, Schumpelick V, Bhardwaj RS, Muys L et al. Expression of the extracellular matrix pro teins collagen I, collagen III and fibronectin and matrix metalloproteinase-1 and -13 in the skin of patients with inguinal hernia. Eur Surg Res 1999;31:480-90. (Pubitemid 30006841)
10. Smigielski J, Kotomecki K, Ziemniak P, Drozda R, Amsolik M, Kuzdak K. Degradation of collagen by metalloproteinase 2 in patients with abdominal hernias. Eur Surg Res 2009;42:118-21.
11. Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B. Collagen I/III and matrix metallopro teinases (MMP) 1 and 13 in the fascia of patients with incisional hernias. J Invest Surg 2001;14:47-54. (Pubitemid 32208463)
12. Rosch R, Lynen-Jansen P, Junge K, Knops M, Klosterhalfen B, Klinge U et al. Biomaterial-dependent MMP-2 expression in fibroblasts from patients with recurrent incisional hernias. Hernia 2006;10:125-30.
13. Rosch R, Junge K, Knops M, Lynen P, Klinge U, Schumpelick V. Analysis of collagen-interacting pro teins in patients with incisional hernias. Langenbecks Arch Surg 2003;387:427-32. (Pubitemid 36343039)
14. Liem MS, van der Graaf Y, Beemer FA, van Vroonhoven TJ. Increased risk for inguinal hernia in patients with Ehlers-Danlos syndrome. Surgery 1997;122:114-5. (Pubitemid 27295175)
15. Kontusaari S, Tromp G, Kuivaniemi H, Romanic AM, Prockop DJ. A mutation in the gene for type III procolla gen (COL3A1) in a family with aortic aneurysms. J Clin Invest 1990;86:1465-73. (Pubitemid 20372592)
16. Lehnert B, Wadouh F. High coincidence of inguinal hernias and abdominal aortic aneurysms. Ann Vasc Surg 1992;6:134-7.
17. Hall KA, Peters B, Smyth SH, Warneke JA, Rappaport WD, Putnam CW et al. Abdominal wall hernias in patients with abdominal aortic aneurysmal versus aortoiliac occlusive disease. Am J Surg 1995;170:572-5.
18. De Cicco C, Ravasi L, Zorzino L, Sandri MT, Botteri E, Verweij F et al. Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive pros tate cancer. Curr Cancer Drug Targets 2008;8:199-206. (Pubitemid 351666856)
19. Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E et al. Circulating levels of matrix met alloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 1999;26:251-8. (Pubitemid 29066724)
20. McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999;29:122-7.
21. Hovsepian DM, Ziporin SJ, Sakurai MK, Lee JK, Curci JA, Thompson RW. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 2000;11:1345-52.
22. Nakamura M, Tachieda R, Niinuma H, Ohira A, Endoh S, Hiramori K et al. Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm. Angiology 2000;51:385-92.
23. Lindholt JS, Vammen S, Fasting H, Henneberg EW, Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 2000;20:281-5.
24. Watanabe T, Sato A, Sawai T, Uzuki M, Goto H, Yamashita H et al. The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair. Ann Vasc Surg 2006;20:317-21.
25. Eugster T, Huber A, Obeid T, Schwegler I, Gürke L, Sti erli P. Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2005;29:378-82. (Pubitemid 40340111)
26. Karlsson L, Bergqvist D, Lindbäck J, Pärsson H. Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma. Eur J Vasc Endovasc Surg 2009;37:420-4.
27. Antoniou SA, Antoniou GA, Granderath FA, Simopoulos C. The role of matrix metalloproteinases in the pathogenesis of abdominal wall hernias. Eur J Clin Invest 2009;39:953-9.
28. Yamashita A, Noma T, Nakazawa A, Saito S, Fujioka K, Zempo N, Esato K. Enhanced expression of matrix met alloproteinase-9 in abdominal aortic aneurysms. World J Surg 2001;25:259-65. (Pubitemid 32410359)
29. Thompson M, Cockerill G. Matrix metalloproteinase-2: the forgotten enzyme in aneurysm pathogenesis. Ann N Y Acad Sci 2006;1085:170-4. (Pubitemid 47092005)
30. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-73. (Pubitemid 43139720)
31. Mandal M, Mandai A, Das S, Chakraborti T, Sajal C. Clinical implications of matrix metalloproteinases. Mol Cell Biochem 2003;252:305-29. (Pubitemid 37220762)